Longitudinal Analysis of Ocular Disease in Children with Mucopolysaccharidosis I after Hematopoietic Cell Transplantation
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 26 (5) , 928-935
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparisonGenetics in Medicine, 2018
- The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler)Acta Ophthalmologica, 2017
- Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis—A Ten-Year Report from the China Children Transplant GroupTransplantation and Cellular Therapy, 2016
- Hematopoietic Cell Transplantation for Mucopolysaccharidosis Patients Is Safe and Effective: Results after Implementation of International GuidelinesTransplantation and Cellular Therapy, 2015
- Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter studyBlood, 2015
- Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioningBlood, 2013
- Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosisActa Ophthalmologica, 2011
- Risk Factor Analysis of Outcomes after Unrelated Cord Blood Transplantation in Patients with Hurler SyndromeTransplantation and Cellular Therapy, 2009
- Mucopolysaccharidoses and the EyeSurvey of Ophthalmology, 2006
- Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation Longer follow-upOphthalmology, 1998